Skip to content

Based on Stem Cell Regulation: Fundamental and Applied Research on the Supramolecular Synergistic Intelligent Response Hydrogel for Regenerating Nucleus Pulposus to Treat Intervertebral Disc Degeneration—Clinical Efficacy Investigation of the Nucleus Regulation Compound in Treating Intervertebral Disc Degeneration

Based on Stem Cell Regulation: Fundamental and Applied Research on the Supramolecular Synergistic Intelligent Response Hydrogel for Regenerating Nucleus Pulposus to Treat Intervertebral Disc Degeneration—Clinical Efficacy Investigation of the Nucleus Regulation Compound in Treating Intervertebral Disc Degeneration

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116042
Enrollment
Unknown
Registered
2026-01-05
Start date
2026-01-05
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intervertebral disc degeneration

Interventions

Observation Group for Intervertebral disc degeneration Treatment:None

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. At least 18 years old (depending on the actual situation), a clear diagnosis of intervertebral disc degeneration is made. 2. People who were diagnosed with intervertebral disc degeneration at the orthopedics department of multiple centers including Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University from January 2020 to January 2025 (or healthy people who participated in physical examinations at the physical examination centers of multiple centers such as Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University).

Exclusion criteria

Exclusion criteria: 1. There are serious complications 2. Those with incomplete clinical data (data collection studies). 3. Clinical samples that do not meet research requirements (sample analysis type research)

Design outcomes

Primary

MeasureTime frame
Pain score;

Countries

China

Contacts

Public ContactZhu Jinjin

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

1659972658@qq.com+86 571 8609 0073

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026